June 25, 2026 10:43 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Amazon's massive India bet! Andy Jassy announces $48 billion investment after meeting PM Modi | Taratala warehouse collapse: Death toll climbs to 8, five arrested as SIT launches probe | Oil prices crash, IndiGo takes off! Aviation and fuel stocks emerge as biggest winners | Passport is a travel document, not conclusive proof of citizenship: MEA | Kolkata: Taratala warehouse roof collapses | Indian Army's Trishakti Corps restores lifeline connectivity in North Bengal between Siliguri and Mirik | 19 million barrels flow through Strait of Hormuz, Trump declares oil prices are falling | No Hindi, no NEET: Vijay reignites Tamil Nadu's biggest political flashpoints | Messi creates World Cup history with record-breaking double; Mbappe equals Klose's mark hours later | Tech giant Oracle slashes 21,000 jobs while betting big on AI

Donald Trump announces new COVID-19 vaccine efforts

| @indiablooms | May 16, 2020, at 01:35 pm

Washington/Xinhua/UNI: US President Donald Trump announced on Friday two men will lead his administration's new effort for COVID-19 vaccine development.

Former pharmaceutical executive Moncef Slaoui and Army General Gustave Perna, the commander of United States Army Materiel Command, will lead "Operation Warp Speed," the new project to accelerate the vaccine development process for COVID-19.

The new project is a "historic partnership" of federal agencies, Trump told a noon briefing in the White House Rose Garden.

He said experts throughout the government have been evaluating 100 vaccine candidates. Among them, 14 vaccine candidates are showing promise.

Trump said he is hopeful a COVID-19 vaccine can be developed by the end of the year.

"Typically pharmaceutical companies wait to manufacture a vaccine until it has received all the regulatory approvals necessary, and this can delay the vaccine's availability to the public as much as a year, even more than that," Trump said.

The federal government will invest in manufacturing all of the top vaccine candidates before they are approved, according to Trump.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine, and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020," said Slaoui, former chair of the vaccines division at pharmaceutical GlaxoSmithKline, a British multinational pharmaceutical company headquartered in London.

He said that in addition to a vaccine, the new project will also focus on the development of medicines for those COVID-19 infected, as well as improving and "optimizing" diagnostic tests. 

Image: Pixabay

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.